Looking forward, the GLP-1 drugs we study (semaglutide, tirzepatide, and emerging oral formulations like orforglipron) are likely only the beginning of a new wave of chronic therapies for conditions like obesity, heart failure, and even kidney disease
[33] Knerr, P
For weekly injectables like semaglutide, the medication reaches peak concentration in your bloodstream approximately one to three days after injection
However, the use of this medication requires a prolonged initial treatment period of dose-escalation to attenuate the adverse gastrointestinal effects (nausea, vomiting, diarrhea) typically associated with GLP-1R agonists, which still occurred frequently but rarely resulted in discontinuation of treatment
The question of whether GLP-1 medications directly slow metabolism requires careful interpretation of available evidence
Do I have to change my diet if I use Rybelsus (Semaglutide)